IL142002A0 - Insulin preparation for pulmonary delivery containing menthol - Google Patents

Insulin preparation for pulmonary delivery containing menthol

Info

Publication number
IL142002A0
IL142002A0 IL14200299A IL14200299A IL142002A0 IL 142002 A0 IL142002 A0 IL 142002A0 IL 14200299 A IL14200299 A IL 14200299A IL 14200299 A IL14200299 A IL 14200299A IL 142002 A0 IL142002 A0 IL 142002A0
Authority
IL
Israel
Prior art keywords
insulin
pulmonary delivery
formulation
insulin preparation
menthol
Prior art date
Application number
IL14200299A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL142002A0 publication Critical patent/IL142002A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL14200299A 1998-10-16 1999-10-15 Insulin preparation for pulmonary delivery containing menthol IL142002A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801326 1998-10-16
PCT/DK1999/000557 WO2000023099A1 (en) 1998-10-16 1999-10-15 Insulin preparations for pulmonary delivery containing menthol

Publications (1)

Publication Number Publication Date
IL142002A0 true IL142002A0 (en) 2002-03-10

Family

ID=8103609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14200299A IL142002A0 (en) 1998-10-16 1999-10-15 Insulin preparation for pulmonary delivery containing menthol

Country Status (20)

Country Link
EP (1) EP1121145B1 (de)
JP (1) JP2002527488A (de)
KR (1) KR20010080132A (de)
CN (1) CN1323220A (de)
AT (1) ATE216258T1 (de)
AU (1) AU758108B2 (de)
BR (1) BR9914568A (de)
CA (1) CA2346884A1 (de)
CZ (1) CZ20011133A3 (de)
DE (1) DE69901314T2 (de)
DK (1) DK1121145T3 (de)
ES (1) ES2177324T3 (de)
HU (1) HUP0103606A3 (de)
IL (1) IL142002A0 (de)
NO (1) NO20011841L (de)
PL (1) PL347171A1 (de)
PT (1) PT1121145E (de)
UA (1) UA67798C2 (de)
WO (1) WO2000023099A1 (de)
ZA (1) ZA200102068B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4868679B2 (ja) 1999-10-14 2012-02-01 ポーラ化成工業株式会社 エレクトロポーレーション用の組成物
US6721595B1 (en) * 1999-10-15 2004-04-13 Pola Chemical Industries Inc. Percutaneous absorption promoters for electroporation
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
CN102596175A (zh) 2009-07-06 2012-07-18 赛诺菲-安万特德国有限公司 含有甲硫氨酸的水性胰岛素制备物
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
MY180661A (en) 2009-11-13 2020-12-04 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PL2611458T3 (pl) 2010-08-30 2017-02-28 Sanofi-Aventis Deutschland Gmbh Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP3229828B1 (de) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin-glargin/lixisenatid-fixierte verhältnisformulierung
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
GB201906917D0 (en) * 2019-05-16 2019-07-03 Intract Pharma Ltd Novel compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
EP0910402B1 (de) * 1996-06-20 2007-08-08 Novo Nordisk A/S INSULINPREPARATION MIT MAnnitol
JP2001518916A (ja) * 1997-03-20 2001-10-16 ノボ ノルディスク アクティーゼルスカブ 結晶インスリンを含有する肺投与のための治療用粉末調合物

Also Published As

Publication number Publication date
KR20010080132A (ko) 2001-08-22
ES2177324T3 (es) 2002-12-01
WO2000023099A1 (en) 2000-04-27
BR9914568A (pt) 2001-07-03
ZA200102068B (en) 2001-10-12
PL347171A1 (en) 2002-03-25
DK1121145T3 (da) 2002-08-12
PT1121145E (pt) 2002-09-30
AU758108B2 (en) 2003-03-13
EP1121145B1 (de) 2002-04-17
HUP0103606A2 (hu) 2002-02-28
AU6189099A (en) 2000-05-08
UA67798C2 (uk) 2004-07-15
CA2346884A1 (en) 2000-04-27
NO20011841L (no) 2001-06-15
DE69901314T2 (de) 2002-11-21
CN1323220A (zh) 2001-11-21
DE69901314D1 (de) 2002-05-23
EP1121145A1 (de) 2001-08-08
CZ20011133A3 (cs) 2001-08-15
JP2002527488A (ja) 2002-08-27
ATE216258T1 (de) 2002-05-15
NO20011841D0 (no) 2001-04-10
HUP0103606A3 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
IL142002A0 (en) Insulin preparation for pulmonary delivery containing menthol
WO1996017587A3 (en) Oral compositions containing stabilized stannous compounds
GEP20043257B (en) Aerosol Particles Resistant to Hygrosscopic Growth, Method for Their Production and Use Thereof for Delivering an Active Agent to the Lung of A Human Patient by Inhalation
ES2091727A1 (es) Formulaciones de analogos de insulina.
ATE277630T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
MY131803A (en) Aerosolized active agent delivery
BR0207005A (pt) Sistema de distribuição granular, processo para prepará-lo, uso do mesmo, produto ou composição flavorizado(a), e, produto ou composição perfumado(a)
ATE390414T1 (de) Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
MY125534A (en) Systems and methods for aerosolizing pharmaceutical formulations
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
MY129112A (en) Flow resistance modulated aerosolized active agent delivery
MY114945A (en) Oral composition
DK1146896T3 (da) Formuleringer, som indeholder monodisperse hexamere acylerede insulin-analoger
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
PL356817A1 (en) Gamma-ifn liquid-droplet aerosol and method
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
Morris Uptake of acetaldehyde vapor and aldehyde dehydrogenase levels in the upper respiratory tracts of the mouse, rat, hamster, and guinea pig
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
AU2615795A (en) Compounds and compositions for administration via oral inhalation or insufflation
DE60103619D1 (de) Pharmazeutische zubereitungen enthaltend alginate
JPS6470061A (en) Deodorant for livestock and its preparation
EP1226821A3 (de) Verwendung von 2,3-Alkylcarbonyloxybenzoesäure zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen